Supplementation with Pycnogenol® relieves symptoms of chronic inflammatory diseases with a significant vasculitis component: a pilot registry study
In conclusion, supplementation with Pycnogenol<sup>®</sup> may offer advantages and management possibilities for patients with vasculitis diseases allowing to avoid more potentially dangerous drug treatments. Considering a prolonged course, it is possible that chronic management with Pycnogenol<sup>®</sup> may prevent the recurrence of diseases with a vasculitis component to clinically significant levels.
Authors
- Beatrice Feragalli (ORCID: https://orcid.org/0000-0002-6222-024X)
- Roberto COTELLESE
- Mark Dugall (ORCID: https://orcid.org/0000-0003-0599-7391)
- Shu HU
- Valeria SCIPIONE
- Claudia SCIPIONE
- G Belcaro
- M R Cesarone
- Umberto Cornelli
- Francesca Coppazuccari
- Morio Hosoi
- David Cox
Institutions
- University of Chieti-Pescara (IT)
- Azienda USL di Pescara (IT)
Publication Details
- Journal
- Minerva Medica
- Published
- 2025-03-31
- DOI
- https://doi.org/10.23736/s0026-4806.24.09579-x
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00